Manager TitleAgeSince
Chief Executive Officer - 2023-11-22
Director of Finance/CFO - 2024-06-13
Chief Tech/Sci/R&D Officer - 2023-12-31
Director TitleAgeSince
Director/Board Member 41 2020-12-31
Chairman 70 2020-12-31
Director/Board Member 35 2019-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+2.99%+15.00% - - 705K
-2.49%-6.35%+51.07%+64.95% 65.42B
-0.63%-2.91%+6.20%+89.22% 58.91B
-2.37%-2.22%+22.87%+82.31% 55.24B
-1.06%-4.69%+13.66%+111.31% 45.66B
-0.67%-6.07%+14.70%+21.31% 41.29B
-0.93%+1.67%+20.83%+45.03% 36.82B
+1.86%-5.06%+134.07%+652.74% 34.48B
-0.80%+0.61%+77.26%+56.26% 32.5B
+0.63%+19.64%-27.39%+488.77% 31.69B
Average -0.31%-0.66%+34.81%+179.10% 45B
Weighted average by Cap. -0.91%-1.28%+32.92%+152.98%
Logo DIAL BIORFD
Diagonal Bio AB is a Sweden-based medical research company. The Company is developing a diagnostic platform (Panviral) for detection of any kind of pathogen. Panviral’s technology is based on rapid isothermal amplification of a pathogen’s genome. Multiple tests can be run in parallel, thereby increasing the sample throughput.
Employees
4